UPDATE 1-Amgen, Cytokinetics heart failure drug misses goal in study Reuters AMSTERDAM, Sept 3 (Reuters) - An experimental heart failure drug from Amgen and Cytokinetics missed its goal of improving shortness of breath in a mid-stage clinical trial, leaving its future uncertain. Shares in Cytokinetics fell 17 percent in pre ... Cytokinetics skids on heart failure drug data UPDATED: PhII flop clouds future of Amgen, Cytokinetics heart failure drug Amgen, Cytokinetics heart failure drug misses goal in study |
